Sonoma Pharmaceuticals, Inc.
SNOA
$5.09
$0.030.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.24M | -776.00K | -928.00K | -610.00K | -1.14M |
| Total Depreciation and Amortization | 36.00K | 31.00K | 33.00K | 35.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -298.00K | 452.00K | -6.00K | 25.00K | 284.00K |
| Change in Net Operating Assets | -512.00K | 198.00K | 1.47M | 904.00K | -92.00K |
| Cash from Operations | -2.02M | -95.00K | 565.00K | 354.00K | -912.00K |
| Capital Expenditure | -106.00K | -47.00K | -2.00K | -26.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -106.00K | -47.00K | -2.00K | -26.00K | -5.00K |
| Total Debt Issued | -- | 274.00K | -- | -- | -- |
| Total Debt Repaid | -81.00K | -81.00K | -82.00K | -122.00K | -119.00K |
| Issuance of Common Stock | 23.00K | 49.00K | 790.00K | 1.57M | 755.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -58.00K | 242.00K | 708.00K | 1.44M | 636.00K |
| Foreign Exchange rate Adjustments | 410.00K | 38.00K | -113.00K | -283.00K | -258.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.77M | 138.00K | 1.16M | 1.49M | -539.00K |